During and even prior to the COVID-19 pandemic, various review committees and other advertising and promotion-related efforts have shifted from in-person to virtual settings. Focus on how to virtually conduct these promotional collaborations while maintaining the essence of in-person partnerships.
- Why is Remote Different from an In-Person Setting?
- Best Practices for Remote Collaboration (e.g., Medical, Legal, and Regulatory Review and Promotional Review Committees)
- Legal Considerations
Rebecca Burnett, Executive Director, Framework Solutions
Virginia Foley, Principal Consultant, Opus Regulatory, Inc.
Michael Smith, Managing Member, Michael F. Smith Law, PLLC
Moderated by Madhavi Bellamkonda, Global Regulatory Advertising & Promotion Leader, Abbott Laboratories
This session was recorded as part of FDLI’s Virtual Introduction to Advertising and Promotion for Medical Products Course in October 2020.